Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients
Dario Cattaneo(ASST Fatebenefratelli Sacco), Emilio Clementi(Luigi Sacco Hospital), Simona Landonio(ASST Fatebenefratelli Sacco), Sara Baldelli(Luigi Sacco Hospital), Gabriella Boreggio(Luigi Sacco Hospital), Valeria Cozzi(Luigi Sacco Hospital), Serena Fucile(Luigi Sacco Hospital), Paola Meraviglia(Luigi Sacco Hospital), Cristina Gervasoni(University of Padua), Giuliano Rizzardini
Cited by 21
Related Papers
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|589
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
|Proceedings of the National Academy of Sciences|2004|496
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
|Cell Death and Disease|2012|265
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
|New England Journal of Medicine|2022|264
Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV
|HIV Medicine|2020|166